Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors

被引:28
作者
Li, C. L. [1 ]
Dionigi, G. [2 ]
Zhao, Y. S. [1 ]
Liang, N. [1 ]
Sun, H. [1 ]
机构
[1] Jilin Univ, Jilin Prov Key Lab Surg Translat Med, Jilin Prov Engn Lab Thyroid Dis Prevent & Control, Div Thyroid Surg,China Japan Union Hosp, Changchun, Jilin, Peoples R China
[2] Univ Messina, Div Endocrine & Minimally Invas Surg, Dept Human Pathol Adulthood & Childhood G Barresi, Univ Hosp G Martino, Via C Valeria 1, I-98125 Messina, Italy
关键词
Obesity; BMI; Papillary thyroid cancer; Thyroid cancer; Clinicopathological features; Ultrasonography; CANCER; OBESITY; RISK; ASSOCIATIONS; CHINA;
D O I
10.1007/s40618-020-01216-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose This retrospective study aimed to assess the association between obesity, gender, and specific clinicopathological features in patients with papillary thyroid cancer (PTC) and whether diagnostic ultrasonography (US) is adversely affected by obesity in these patients. Materials and methods This study retrospectively analyzed 13,995 adult patients with PTC from a single medical center in China. Data stratification was performed to assess the association of obesity with US features and aggressive clinicopathological features in different models according to the World Health Organization Body Mass Index (WHO-BMI) and Chinese BMI classification (CN-BMI). The odds ratio (OR) of malignant US features and aggressive clinicopathological features was calculated from binary logistic regression models. Results The BMI, obesity ratio, malignant US features, and aggressive pathological characteristics of males were significantly higher than those of females. After adjusting for confounding factors, the association of obesity with malignant US features and aggressive pathological characteristics was found to be sex-dependent. Next, obesity (WHO-BMI) was found to have an "interfering effect" on the US assessment of PTC (OR = 0.754, 95% CI 0.609-0.932,P = 0.009) in women. Among both sexes, obesity (WHO-BMI) increased the risk of tumor size (ORmale = 1.539 and ORfemale = 1.521) and multifocality (ORmale = 1.659 and ORfemale = 1.449). However, obesity did not increase the risk of capsular invasion or tumor staging in males. The above results are consistent with the CN-BMI. In addition, age was found to have an "interfering effect" on the US evaluation of malignant nodules in both sexes. Conclusion The results of our study confirm that higher BMI is significantly associated with aggressive clinicopathological features of PTC. Gender differences were present with obesity ratios and aggressive clinicopathological features being significantly higher in men.
引用
收藏
页码:1283 / 1299
页数:17
相关论文
共 25 条
  • [1] [Anonymous], 2016, CHIN J DIABETES MELL, V8, P525, DOI [10.3760/cma.j.issn.1674-5809.2016.09.004, DOI 10.3760/cma.j.issn.1674-5809.2016.09.004]
  • [2] Cancer Statistics in China, 2015
    Chen, Wanqing
    Zheng, Rongshou
    Baade, Peter D.
    Zhang, Siwei
    Zeng, Hongmei
    Bray, Freddie
    Jemal, Ahmedin
    Yu, Xue Qin
    He, Jie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) : 115 - 132
  • [3] Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma
    Choi, Ji Soo
    Kim, Eun-Kyung
    Moon, Hee Jung
    Kwak, Jin Young
    [J]. ENDOCRINE, 2015, 48 (01) : 264 - 271
  • [4] Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants
    Di Cesare, Mariachiara
    Bentham, James
    Stevens, Gretchen A.
    Zhou, Bin
    Danaei, Goodarz
    Lu, Yuan
    Bixby, Honor
    Cowan, Melanie J.
    Riley, Leanne M.
    Hajifathalian, Kaveh
    Fortunato, Lea
    Taddei, Cristina
    Bennett, James E.
    Ikeda, Nayu
    Khang, Young-Ho
    Kyobutungi, Catherine
    Laxmaiah, Avula
    Li, Yanping
    Lin, Hsien-Ho
    Miranda, J. Jaime
    Mostafa, Aya
    Turley, Maria L.
    Paciorek, Christopher J.
    Gunter, Marc
    Ezzati, Majid
    Abdeen, Ziad A.
    Hamid, Zargar Abdul
    Abu-Rmeileh, Niveen M.
    Acosta-Cazares, Benjamin
    Adams, Robert
    Aekplakorn, Wichai
    Aguilar-Salinas, Carlos A.
    Ahmadvand, Alireza
    Ahrens, Wolfgang
    Ali, Mohamed M.
    Alkerwi, Ala'a
    Alvarez-Pedrerol, Mar
    Aly, Eman
    Amouyel, Philippe
    Amuzu, Antoinette
    Andersen, Lars Bo
    Anderssen, Sigmund A.
    Andrade, Dolores S.
    Anjana, Ranjit Mohan
    Aounallah-Skhiri, Hajer
    Ariansen, Inger
    Aris, Tahir
    Arlappa, Nimmathota
    Arveiler, Dominique
    Assah, Felix K.
    [J]. LANCET, 2016, 387 (10026) : 1377 - 1396
  • [5] Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study
    Dieringer, Peter
    Klass, Evan M.
    Caine, Brenna
    Smith-Gagen, Julie
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 93 - 98
  • [6] Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma
    Feng, Jia-Wei
    Yang, Xing-Hai
    Wu, Bao-Qiang
    Sun, Dong-Lin
    Jiang, Yong
    Qu, Zhen
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (07) : 625 - 632
  • [7] The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer
    Gasior-Perczak, Danuta
    Palyga, Iwona
    Szymonek, Monika
    Kowalik, Artur
    Walczyk, Agnieszka
    Kopczynski, Janusz
    Lizis-Kolus, Katarzyna
    Trybek, Tomasz
    Mikina, Estera
    Szyska-Skrobot, Dorota
    Gadawska-Juszczyk, Klaudia
    Hurej, Stefan
    Szczodry, Artur
    Sluszniak, Anna
    Sluszniak, Janusz
    Mezyk, Ryszard
    Gozdz, Stanislaw
    Kowalska, Aldona
    [J]. PLOS ONE, 2018, 13 (10):
  • [8] Lack of association between obesity and aggressiveness of differentiated thyroid cancer
    Grani, G.
    Lamartina, L.
    Montesano, T.
    Ronga, G.
    Maggisano, V.
    Falcone, R.
    Ramundo, V.
    Giacomelli, L.
    Durante, C.
    Russo, D.
    Maranghi, M.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (01) : 85 - 90
  • [9] Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study
    Huang, Huang
    Rusiecki, Jennifer
    Zhao, Nan
    Chen, Yingtai
    Ma, Shuangge
    Yu, Herbert
    Ward, Mary H.
    Udelsman, Robert
    Zhang, Yawei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (08) : 1209 - 1218
  • [10] Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer
    Kim, Hye Jeong
    Kim, Na Kyung
    Choi, Ji Hun
    Sohn, Seo Young
    Kim, Se Won
    Jin, Sang-Man
    Jang, Hye Won
    Suh, Sunghwan
    Min, Yong-Ki
    Chung, Jae Hoon
    Kim, Sun Wook
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 78 (01) : 134 - 140